These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 10828764

  • 1. Progression of renal damage in chronic rejection.
    Ponticelli C.
    Kidney Int Suppl; 2000 Apr; 75():S62-70. PubMed ID: 10828764
    [Abstract] [Full Text] [Related]

  • 2. Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion.
    Monaco AP, Burke JF, Ferguson RM, Halloran PF, Kahan BD, Light JA, Matas AJ, Solez K.
    Am J Kidney Dis; 1999 Jan; 33(1):150-60. PubMed ID: 9915283
    [Abstract] [Full Text] [Related]

  • 3. Protocol biopsies after kidney transplantation.
    Böhmig GA, Regele H, Hörl WH.
    Transpl Int; 2005 Feb; 18(2):131-9. PubMed ID: 15691264
    [Abstract] [Full Text] [Related]

  • 4. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR, Ghafari A, Hajizadeh E, Kazemnejad A.
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [Abstract] [Full Text] [Related]

  • 5. Chronic allograft nephropathy. A multiple approach to target nonimmunological factors.
    Ruggenenti P.
    Contrib Nephrol; 2005 Dec; 146():87-94. PubMed ID: 15567923
    [No Abstract] [Full Text] [Related]

  • 6. Rejection and function and chronic allograft dysfunction.
    de Fijter JW.
    Kidney Int Suppl; 2010 Dec; (119):S38-41. PubMed ID: 21116316
    [Abstract] [Full Text] [Related]

  • 7. Chronic allograft nephropathy.
    Najafian B, Kasiske BL.
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
    [Abstract] [Full Text] [Related]

  • 8. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.
    Schwarz C, Regele H, Huttary N, Wahrmann M, Exner M, Nagy-Bojarsky K, Kletzmayr J, Hörl WH, Böhmig GA.
    Wien Klin Wochenschr; 2006 Jul; 118(13-14):397-404. PubMed ID: 16865644
    [Abstract] [Full Text] [Related]

  • 9. The problem of late allograft loss in kidney transplantation.
    Cardarelli F, Saidman S, Theruvath T, Tolkoff-Rubin N, Cosimi AB, Pascual M.
    Minerva Urol Nefrol; 2003 Mar; 55(1):1-11. PubMed ID: 12773962
    [Abstract] [Full Text] [Related]

  • 10. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
    Yu P, Wang Z, Liu Y, Xiao Z, Guo Y, Li M, Zhao M.
    Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
    [Abstract] [Full Text] [Related]

  • 11. New insights in chronic allograft rejection.
    Paul LC.
    Curr Opin Urol; 2002 Mar; 12(2):89-93. PubMed ID: 11859253
    [Abstract] [Full Text] [Related]

  • 12. Chronic renal allograft dysfunction (CAD): new frontiers. Introduction.
    Sayegh MH.
    Kidney Int Suppl; 2010 Dec; (119):S1. PubMed ID: 21116309
    [No Abstract] [Full Text] [Related]

  • 13. Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Li J, Basler M, Alvarez G, Brunner T, Kirk CJ, Groettrup M.
    Kidney Int; 2018 Mar; 93(3):670-680. PubMed ID: 29229189
    [Abstract] [Full Text] [Related]

  • 14. Clinical correlates to chronic renal allograft rejection.
    Kasiske BL.
    Kidney Int Suppl; 1997 Dec; 63():S71-4. PubMed ID: 9407426
    [Abstract] [Full Text] [Related]

  • 15. Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens.
    Merville P.
    Drugs; 2005 Dec; 65(5):615-31. PubMed ID: 15748097
    [Abstract] [Full Text] [Related]

  • 16. Chronic rejection and late renal allograft dysfunction.
    Laine J, Holmberg C, Häyry P.
    Pediatr Nephrol; 1996 Apr; 10(2):221-9. PubMed ID: 8703719
    [Abstract] [Full Text] [Related]

  • 17. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.
    Transplantation; 2014 Mar 27; 97(6):642-7. PubMed ID: 24637863
    [Abstract] [Full Text] [Related]

  • 18. Chronic allograft nephropathy--clinical guidance for early detection and early intervention strategies.
    Serón D, Arns W, Chapman JR.
    Nephrol Dial Transplant; 2008 Aug 27; 23(8):2467-73. PubMed ID: 18385386
    [No Abstract] [Full Text] [Related]

  • 19. Non-immune interventions to protect kidney allografts in the long term.
    Cravedi P, Perico N, Remuzzi G.
    Kidney Int Suppl; 2010 Dec 27; (119):S71-5. PubMed ID: 21116322
    [Abstract] [Full Text] [Related]

  • 20. Induction of chronic renal allograft dysfunction in a rat model with complete and exclusive MHC incompatibility.
    Poehnert D, Broecker V, Mengel M, Nashan B, Koch M.
    Transpl Immunol; 2010 Feb 27; 22(3-4):137-43. PubMed ID: 19815070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.